CellWell record HH-459827
Effect of dotinurad versus febuxostat on the one-year eGFR slope in CKD patients with hyperuricemia: a retrospective cohort study
Hikaru Uematsu; Tatsunori Toida; Yuri Tanaka; Nobuhiko Joki
2026
In plain language
In 81 chronic kidney disease patients with hyperuricemia, starting dotinurad was associated with a more favorable one-year eGFR slope than febuxostat, though the small observational design makes the finding hypothesis-generating.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-459827
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.